Influx Healthtech IPO KPI Information
The Influx Healthtech IPO KPI (Key Performance Indicators) provide valuable insights into the company's financial efficiency, profitability, and capital utilization. Key metrics such as Return on Equity (ROE), Return on Capital Employed (ROCE), Debt-to-Equity Ratio, Return on Net Worth (RoNW), Price-to-Book Value (P/BV), and PAT Margin help investors evaluate the company's operational performance and financial health before investing in the IPO.
Based on the latest reported financial year (KPI as of Mon, Mar 31, 2025), Influx Healthtech Limited reported ROE of 36.98%, ROCE of 49.17%, RoNW of 36.98%, PAT Margin of 12.75%, Debt-to-Equity Ratio of 0.01, and Price-to-Book Value (P/BV) of 7.62. These key financial ratios provide investors with a snapshot of the company's profitability, capital efficiency, leverage, and overall financial strength.
Influx Healthtech IPO Key Performance Indicators
- Return on Equity (ROE): 36.98%
- Return on Capital Employed (ROCE): 49.17%
- Return on Net Worth (RoNW): 36.98%
- PAT Margin: 12.75%
- Debt-to-Equity Ratio: 0.01
- Price-to-Book Value (P/BV): 7.62
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Influx Healthtech Limited KPI Information
| Particular | KPI as of Mon, Mar 31, 2025 |
|---|---|
| ROE % | 36.98 |
| ROCE % | 49.17 |
| Debt / Equity | 0.01 |
| RoNW % | 36.98 |
| PbW | 7.62 |
| Pat Margin % | 12.75 |
Return Ratio
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Market Cap of Influx Healthtech Limited?
The post-IPO market capitalisation (market cap) of Influx Healthtech Limited is approximately ₹222.24 crore, based on the IPO issue price and the company's post-issue equity share capital. Market cap represents the total market value of a company's outstanding shares and is widely used by investors to assess the company's size and valuation.
What is the ROE of Influx Healthtech Limited?
Influx Healthtech Limited reported a Return on Equity (ROE) of 36.98% as of KPI as of Mon, Mar 31, 2025. ROE measures how efficiently the company generates profits from shareholders' equity. A higher ROE generally indicates strong financial performance and effective management of shareholder funds.
What is the ROCE of Influx Healthtech Limited?
The Return on Capital Employed (ROCE) of Influx Healthtech Limited stood at 49.17% as of KPI as of Mon, Mar 31, 2025. ROCE measures how efficiently the company uses its total capital to generate profits. A higher ROCE indicates better capital efficiency and operational performance.
What is the Net Profit Margin (PAT Margin) of Influx Healthtech Limited?
Influx Healthtech Limited reported a Profit After Tax (PAT) Margin of 12.75% as of KPI as of Mon, Mar 31, 2025. PAT Margin shows the percentage of revenue that remains as net profit after all operating expenses, interest, and taxes. A higher margin reflects better profitability and cost management.
What is the Return on Net Worth (RoNW) of Influx Healthtech Limited?
The Return on Net Worth (RoNW) of Influx Healthtech Limited was 36.98% as of KPI as of Mon, Mar 31, 2025. RoNW measures the company's ability to generate profits from shareholders' net worth and is an important indicator of overall financial efficiency.